LTK
Summary: The protein encoded by this gene is a member of the ros/insulin receptor family of tyrosine kinases. Tyrosine-specific phosphorylation of proteins is a key to the control of diverse pathways leading to cell growth and differentiation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| leukocyte receptor tyrosine kinase | MIM:151520 | Ensembl:ENSG00000062524 | HGNC:HGNC:6721 | PA30483 | 15q15.1 |
GO terms in LTK
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | IDA | GO:0004672 | protein kinase activity |
| MF | IBA | GO:0004709 | MAP kinase kinase kinase activity |
| MF | IBA | GO:0004713 | protein tyrosine kinase activity |
| MF | TAS | GO:0004713 | protein tyrosine kinase activity |
| MF | IBA | GO:0004714 | transmembrane receptor protein tyrosine kinase activity |
| MF | IEA | GO:0004714 | transmembrane receptor protein tyrosine kinase activity |
| MF | IBA | GO:0004888 | transmembrane signaling receptor activity |
| MF | IPI | GO:0005515 | protein binding |
| MF | IEA | GO:0005524 | ATP binding |
| MF | IBA | GO:0031434 | mitogen-activated protein kinase kinase binding |
| CC | IEA | GO:0005622 | intracellular |
| CC | IBA | GO:0005737 | cytoplasm |
| CC | TAS | GO:0005886 | plasma membrane |
| CC | IBA | GO:0005887 | integral component of plasma membrane |
| CC | TAS | GO:0005887 | integral component of plasma membrane |
| CC | IDA | GO:0016020 | membrane |
| CC | IBA | GO:0043235 | receptor complex |
| BP | IBA | GO:0001934 | positive regulation of protein phosphorylation |
| BP | IDA | GO:0006468 | protein phosphorylation |
| BP | TAS | GO:0007165 | signal transduction |
| BP | IEA | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway |
| BP | IBA | GO:0007275 | multicellular organism development |
| BP | IDA | GO:0008283 | cell proliferation |
| BP | IBA | GO:0009968 | negative regulation of signal transduction |
| BP | IDA | GO:0010666 | positive regulation of cardiac muscle cell apoptotic process |
| BP | IMP | GO:0010976 | positive regulation of neuron projection development |
| BP | IMP | GO:0014065 | phosphatidylinositol 3-kinase signaling |
| BP | IEA | GO:0018108 | peptidyl-tyrosine phosphorylation |
| BP | IBA | GO:0030154 | cell differentiation |
| BP | IBA | GO:0033674 | positive regulation of kinase activity |
| BP | IBA | GO:0043066 | negative regulation of apoptotic process |
| BP | IMP | GO:0043066 | negative regulation of apoptotic process |
| BP | IBA | GO:0070374 | positive regulation of ERK1 and ERK2 cascade |
| BP | IMP | GO:0071300 | cellular response to retinoic acid |
Gene expression in normal tissue: LTK
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in LTK
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD546 | BMS-754807 | 2 |
| iGMDRD427 | ABT737 | 2 |
| iGMDRD494 | Neopeltolide | 4 |
| iGMDRD126 | Tipifarnib | 2 |
| iGMDRD889 | Compound 7d-cis | 2 |
| iGMDRD772 | BRD4770 | 2 |
| iGMDRD420 | Leucascandrolide A | 2 |
| iGMDRD1008 | SR-II-138A | 2 |
| iGMDRD579 | PF750 | 5 |
| iGMDRD466 | Chaetocin | 3 |
| iGMDRD634 | SCHEMBL2608041 | 3 |
| iGMDRD375 | GW-405833 | 5 |
| iGMDRD446 | LY 2183240 | 2 |
| iGMDRD201 | SKI II | 3 |
| iGMDRD193 | Fqi1 | 3 |
| iGMDRD885 | Compound 110 | 3 |
| iGMDRD52 | Rotenone | 2 |
| iGMDRD270 | Ciclosporin | 2 |
| iGMDRD802 | 4-methylfasudil | 5 |
| iGMDRD64 | Parbendazole | 4 |
| iGMDRD268 | Cerulenin | 2 |
| iGMDRD23 | Gossypol | 2 |
| iGMDRD524 | ISX-9 | 2 |
| iGMDRD188 | Piperlongumine | 2 |
| iGMDRD100 | Zebularine | 2 |
| iGMDRD74 | Idarubicin | 2 |
| iGMDRD887 | Compound 23 citrate | 2 |
| iGMDRD888 | Compound 44 | 1 |
| iGMDRD577 | BIX01294 | 5 |
| iGMDRD506 | Fedratinib | 7 |
| iGMDRD562 | Navitoclax | 4 |
| iGMDRD424 | Tamatinib | 1 |
| iGMDRD652 | UNC0638 | 2 |
| iGMDRD79 | Gemcitabine | 5 |
| iGMDRD901 | ELCPK | 3 |
| iGMDRD123 | Isoevodiamine | 2 |
| iGMDRD154 | NSC23766 | 3 |
| iGMDRD314 | Tanespimycin | 2 |
| iGMDRD221 | Tamoxifen | 3 |
| iGMDRD481 | Dactolisib | 3 |
| iGMDRD77 | Itraconazole | 5 |
| iGMDRD213 | SMR000068650 | 1 |
| iGMDRD137 | Indisulam | 4 |
| iGMDRD300 | Tozasertib | 3 |
| iGMDRD505 | Pevonedistat | 2 |
| iGMDRD246 | NPC26 | 2 |
| iGMDRD286 | Nsc 632839 | 3 |
| iGMDRD367 | Ro 28-1675 | 3 |
| iGMDRD872 | BRD7137 | 2 |
| iGMDRD329 | Merck60 | 2 |
| iGMDRD269 | Purmorphamine | 3 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in LTK

